Related Experiment Videos
Developments in mechanical support as a bridge to cardiac transplant
1Division of Cardiac Surgery, Ottawa Heart Institute, Ottawa, Ontario. phendry@ottawaheart.ca
The Canadian Journal of Cardiology
|April 2, 2004
Summary
Mechanical circulatory support devices offer a viable alternative for Canadians with congestive heart failure due to donor heart scarcity. Their use shows promise as a life-saving intervention, though cost-effectiveness requires careful consideration against other treatments.
Area of Science:
- Cardiology
- Medical Devices
- Transplantation Medicine
Background:
- Increasing incidence of congestive heart failure necessitates advanced treatment options.
- Limited availability of donor hearts restricts heart transplantation success.
- Mechanical circulatory support (MCS) devices are gaining prominence in cardiac care.
Purpose of the Study:
- To present indications for MCS device use in Canada.
- To detail available MCS pump types and performing centers.
- To review the outcomes of MCS device implantation in Canadian patients.
Main Methods:
- Review of current practices and outcomes for MCS devices in Canada.
- Analysis of indications, device types, and procedural centers.
- Evaluation of the effectiveness and cost implications of MCS devices.
Main Results:
- MCS devices are increasingly utilized in Canada for heart failure management.
- These devices represent a potentially life-saving option for patients ineligible for transplantation.
- The study outlines specific indications, pump technologies, and Canadian centers involved.
Conclusions:
- Mechanical circulatory support devices are a reasonable alternative for patients with severe heart failure in Canada.
- Further analysis is needed to compare the cost-effectiveness of MCS devices with other life-saving medical technologies.
- Widespread adoption of these devices necessitates a thorough economic evaluation.